← Back
Data updated: Mar 29, 2026
VIVUS INC
MetabolicOncology
Biotech
VIVUS INC is a biotechnology company focused on Metabolic, Oncology. Key products include QSYMIA.
2010
Since
3
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 80%
1 drugs Phase 1: 2
Oncology 20%
0 drugs Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...